Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3SC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,863
Award facts
- Contract value 100% obligated
- $39,862.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,862.95 delivery order to AmerisourceBergen Drug Corp for Stelara 45 mg/0.5 mL syringes on January 22, 2026, with an ultimate completion date of January 23, 2026. This is a firm fixed-price contract with no set-aside designation, awarded competitively. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military healthcare programs globally.
Stelara is a specialty biologic medication used to treat autoimmune and inflammatory conditions including plaque psoriasis, psoriatic arthritis, and Crohn's disease. Through its extensive federal contract portfolio with the Defense Logistics Agency and Department of Veterans Affairs, Cencora, Inc. demonstrates substantial capability in fulfilling government pharmaceutical procurement needs across multiple therapeutic domains. The company's DLA Troop Support Medical IDC enables efficient delivery of essential medications and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide, making this Stelara order part of a critical supply chain supporting military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FG3SC?
SPE2DR26FG3SC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FG3SC worth?
The government has obligated $39,863 on SPE2DR26FG3SC.
Is contract SPE2DR26FG3SC an order under another contract?
Yes. SPE2DR26FG3SC is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3SC competed?
The extent of competition for SPE2DR26FG3SC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award